Re: ZEN-3694 mCRPC Trial Status
in response to
by
posted on
Oct 26, 2017 12:57PM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
Toniv asked in his previous post "So what are the options for me to get money for my shares?" in regards to selling a "star" from the Star Factory. Great question for the AGM!
As for your inquiry of Q&A during the BIO Investor Forum last week.....these were short presentations that were not structured to allow for Q&A following the presentation. Short time slots of ~15 minutes, taken up entirely by the presentation. I think they encourage 1 on 1 meetings for follow up.
BearDownAZ